2023 annual financial data
Regencell Bioscience 2023 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -6,273,671 USD and net income was -5,871,130 USD.
Operating cash flow was -4,962,949 USD.
Get free Regencell Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -6,273,671 USD
- Net income
- -5,871,130 USD
- Operating cash flow
- -4,962,949 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Regencell Bioscience financial years